NeuroTek Medical Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

NeuroTek Medical General Information


Developer of a non-invasive, electronic neuromodulation device intended to treat pathological diseases. The company's device is battery operated and self-administered that can safely and transcutaneously stimulate the occipital nerve for treating migraines, enabling patients to have a cost-effective option for immediate relief at the onset of a migraine.

Contact Information

Ownership Status
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Therapeutic Devices
Primary Office
  • Dallas, TX
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NeuroTek Medical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 22-Apr-2016 Completed Startup
2. Product Crowdfunding 01-Jan-2014 Cancelled Startup
1. Accelerator/Incubator 01-Jan-2013 Completed Startup
To view NeuroTek Medical’s complete valuation and funding history, request access »

NeuroTek Medical Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Health Wildcatters Accelerator/Incubator Minority 000 0000 000000 0
To view NeuroTek Medical’s complete investors history, request access »